The largest database of trusted experimental protocols

P3 primary cell nucleofector solution with supplement 1

Manufactured by Lonza

The P3 Primary Cell Nucleofector Solution with Supplement 1 is a transfection reagent designed for the electroporation of primary cells. It is intended to facilitate the efficient delivery of nucleic acids, such as plasmids, into mammalian primary cell types.

Automatically generated - may contain errors

2 protocols using p3 primary cell nucleofector solution with supplement 1

1

CRISPR-Cas9 Gene Knockout in Primary T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CRISPR-Cas9–mediated gene knockout in primary T cells was performed with some modifications to a previous protocol (Seki and Rutz, 2018 (link); Oh et al., 2019 (link)). Briefly, naïve T cells from KRN transgenic mice were purified by negative isolation and assessed for counts and purity. Each sgRNA (Synthego, sequences listed below) was incubated with Alt-R S.p. Cas9 Nuclease V3 (Integrated DNA Technologies) for 10 min at room temperature to form a separate RNP complex, then combined into a single tube for each nucleofection condition. Cells were resuspended in P3 Primary Cell Nucleofector Solution with Supplement 1 (Lonza) plus Alt-R Cas9 Electroporation Enhancer (Integrated DNA Technologies) and immediately aliquoted to the tubes with combined RNP complexes. Mixed cells and sgRNA-Cas9 complexes were transferred to nucleocuvette wells (Lonza) and pulsed with the DN100 program on a Lonza 4D-Nucleofector. Electroporated cells were resuspended and washed in complete media, then assessed again for viable cell counts. KRN T cells were resuspended in sterile PBS prior to intravenous transfer (2 × 105 cells) into B6.I-Ab/g7 recipients. CRISPR sgRNA sequences used are given in Table 2.
+ Open protocol
+ Expand
2

Nucleofection of Hematopoietic Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hematopoietic stem and progenitor cells were counted after two days and centrifuged at 300 g for 10 minutes. T-cells were counted after 4–6 days in culture. Supernatant was removed and cells were resuspended in P3 Primary Cell Nucleofector® Solution with Supplement 1 (Lonza, V4XP-3032) at 5–15 million cell/mL. Cell mixture was transferred to Lonza strip at 20 μL per well and electroporated using program DZ100 with solution setting P3. 80 μL of StemSpan SFEM II supplemented with StemSpan CD34+ Expansion Supplement (10X) (StemCell Technologies, Catalog #09720) was added to each well. AAV was added after electroporation, if necessary, at 104 vg/cell. HSPCs were transferred to 24-well non-treated plates at a density of 100,000 cells/mL and incubated at 37°C for 2–3 days. T-cells were cultured at densities of 500,000–1,000,000 cells/mL.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!